UBS initiated coverage of Sabra Health Care (SBRA) with a Neutral rating and $20 price target The company should benefit from demographic tailwinds, a favorable skilled nursing facility backdrop, and expanding rent coverage ratios, the analyst tells investors in a research note. However, the firm believes this is already priced into the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SBRA:
- Hold Rating for Sabra Healthcare REIT Amidst Balanced Valuation and Strategic Challenges
- Sabra Health Care REIT Reports Strong Q3 2025 Results
- Sabra Healthcare REIT’s Optimistic Earnings Call Analysis
- Sabra Healthcare REIT: Balancing Strong FAD Performance with Capital Cost Challenges
- Sabra Healthcare REIT Reports Q3 Results and Upgraded Rating